Test Report

    Tesamorelin — 26030604-03

    Summary

    Batch 26030604-03 (product no. 800052) tested at 99.4% purity by HPLC against a 98% minimum. Mass spectrum matched the expected 5135.9 ± 1.0.

    Findings

    White powder, soluble in water. Amino acid ratios matched the expected sequence. Peptide content 84.9%, acetic acid 11.0% and water 3.4%. Residual solvents, bacterial endotoxins and microbial limits all within specification. Manufactured 6 March 2026, retest date 5 March 2028.

    Results

    Purity (HPLC)99.4% (spec. ≥ 98.0%)
    Mass spectrum5136.6 (spec. 5135.9 ± 1.0)
    Peptide content84.9% (spec. ≥ 80.0%)
    Acetic acid11.0% (spec. ≤ 15.0%)
    Water content3.4% (spec. ≤ 8.0%)
    TrifluoroacetateNot detected (spec. ≤ 0.5%)
    Residual solventsWithin limits
    Bacterial endotoxinsConforms (spec. ≤ 10 EU/mg)
    Microbial limitsConforms

    Certificate of Analysis

    Download PDF
    Tesamorelin certificate of analysis, batch 26030604-03, page 1 of 2Tesamorelin certificate of analysis, batch 26030604-03, page 2 of 2

    Report Details

    Product

    Tesamorelin

    Batch Number

    26030604-03

    Test Date

    March 2026

    Purity

    99.4%

    Method

    HPLC & Mass Spectrometry

    Tested by

    Manufacturer quality control

    View product